L-Dopa and imipramine: biochemical and behavioral interaction.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001522:Behavior, Animal / Q000187:drug effects*; D001593:Benzyl Compounds / Q000494:pharmacology; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D003984:Dibenzazepines / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis; D004347:Drug Interactions; D006834:Hydrazines / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis; D051381:Rats; D012694:Serine / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis; D014316:Tritium
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001593:Benzyl Compounds; D003984:Dibenzazepines; D006834:Hydrazines; D014316:Tritium; D012701:Serotonin; D012694:Serine; D004295:Dihydroxyphenylalanine; D007099:Imipramine; D004298:Dopamine; D009638:Norepinephrine